Collectively, the results from our cell lines and TCGA ccRCC RNA-seq results indicated that FoxP3 might play a pro-oncogenic role in ccRCC by activating immune-related pathways and by recruiting more Treg cells into the tumor microenvironment. The gene discussed is FOXP3; the disease is neoplasm.